GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) effectively manage type 2 diabetes and promote weight loss, but their gastrointestinal effectsincluding nausea, vomiting, and diarrheacan disrupt fluid and electrolyte balance
Proline aids in tissue repair and circulatory health
The Science Behind Mounjaro and Its Effects Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist, meaning it mimics natural gut hormones that regulate appetite, glucose levels, and insulin secretion
But rapid, significant weight loss of this kind produces effects on skin and body composition that most people aren't warned about at the outset
I just think people should be active
In extreme cases, complications can lead to Stevens-Johnson syndrome or kidney failure